A nasal cannula. Image: Amsterdam UMC.
A nasal cannula. Image: Amsterdam UMC. A specific type of nasal oxygen therapy for Covid patients does not cause a higher risk of virus infection for health care workers. In an article in Respiratory Care, researchers from the group of Daniel Bonn (UvA-IoP) and from the Amsterdam UMC conclude that this therapy does not increase the risk of aerosol formation. The result may help in lessening the pressure on ICUs. According to the researchers, which include UvA physicists Daniell Bonn and Stefan Kooij, the result takes away the worries about the use of high flow nasal oxygen (HFNO). This is a special technique used to administer a high flow of heated and moistened oxygen to the (Covid) patient through a nasal cannula.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
